GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (FRA:PHS) » Definitions » Inventories, Finished Goods

PhotoCure ASA (FRA:PHS) Inventories, Finished Goods : €0.00 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is PhotoCure ASA Inventories, Finished Goods?

PhotoCure ASA's annual finished goods declined from Dec. 2021 (€0.02 Mil) to Dec. 2022 (€0.01 Mil) but then increased from Dec. 2022 (€0.01 Mil) to Dec. 2023 (€0.01 Mil).


PhotoCure ASA Inventories, Finished Goods Historical Data

The historical data trend for PhotoCure ASA's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhotoCure ASA Inventories, Finished Goods Chart

PhotoCure ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.01 0.02 0.01 0.01

PhotoCure ASA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.01 - - -

PhotoCure ASA Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


PhotoCure ASA Business Description

Traded in Other Exchanges
Address
Hoffsveien 4, Oslo, NOR, 0275
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, and the United States.

PhotoCure ASA Headlines

No Headlines